Reason for request
Renewal of inclusion on the list of medicines refundable by National Health Insurance and Re-assessment of the actual benefit following the Transparency Committee conclusions in its opinions of 26 November 2008 and reiterated in its opinion of 21 September 2011.
Clinical Benefit
| Insufficient |
The actual benefit of CHONDROSULF 400 mg capsules and granules is insufficient to justify reimbursement by National Insurance. |
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
rMjFTwBPy6muGC9T
